From a Canada CNF to a UK SCPN Notification

Say you've already got a product notified in Canada and a UK retailer wants to carry it. The instinct is to assume most of the work is done, since you already have a formula sheet, INCI list, and a CN number sitting in a folder somewhere. Some of that instinct is right. Some of it will leave gaps if you don't check carefully.

Two different systems solving a similar problem

Canada's Cosmetic Notification Form, filed through the Cosmetic Notification System, is a notification model: you tell Health Canada what you're selling, within 10 days of first sale, and you receive a Cosmetic Notification number back. The UK, post-Brexit, runs its own notification system through the Office for Product Safety and Standards, called Submit Cosmetic Product Notification, or SCPN. Both are notification-based rather than pre-approval systems, which is the part of the structure that does carry over conceptually. But the specific data fields, the responsible party requirements, and the underlying substance lists are separately governed, and none of that is automatically compatible.

What genuinely transfers from your CNF work

• Your full ingredient list by INCI name. This is the backbone of both filings and the part of your existing work that's most directly reusable.
• Concentration or concentration ranges for each ingredient, assuming you kept that data at the individual-ingredient level rather than folding supplier blends into one line item.
• Your general formulation and manufacturing documentation, since both markets expect you to be able to describe how the product is made.
• Institutional knowledge of your own product, meaning you already know your intended use, packaging, and claims, which saves real time versus starting from a blank page.

What does not transfer and needs fresh attention

A UK-established Responsible Person. This is the biggest structural gap. Canada's CNF does not require a Canadian address holding legal responsibility in the same way the UK model does. For the UK, you need an entity established in the UK who takes on responsibility for the product there. A Canadian company address on your CNF paperwork does not satisfy this. This is very similar in spirit to the EU's Responsible Person requirement, and brands who already sell into the EU sometimes already have this piece solved through the same RP relationship, but it needs to be explicitly extended or confirmed for the UK specifically.

Ingredient legality against a different list. An ingredient permitted at a given concentration under Canada's Cosmetic Ingredient Hotlist is not automatically permitted at the same concentration, or at all, under UK requirements. Every ingredient needs to be checked again against the market you're entering, not assumed compliant because it cleared a different regulator.

Fragrance allergen disclosure timing and thresholds. Canada's own allergen disclosure rules are on their own timeline (List 1 mandatory April 12, 2026, and List 2 mandatory August 1, 2026, above 0.001% in leave-on and 0.01% in rinse-off products). The UK has its own allergen disclosure framework and its own list. Don't assume the Canadian trigger thresholds or list contents map one-to-one onto the UK's requirement; check the UK-specific rule directly.

Label requirements. Canadian labels must be bilingual, English and French. The UK has entirely different labeling expectations. A label built to satisfy Health Canada is very unlikely to satisfy UK requirements without changes.

A rough side-by-side

Item	Canada CNF	UK SCPN
Filing type	Notification	Notification
Filed by	Seller	Responsible entity in the UK
Timing	Within 10 days of first sale	Per OPSS current guidance, check directly
Confirmation	CN number	SCPN record
Language on label	Bilingual English/French	UK-specific requirements
Ingredient list check	Against the Cosmetic Ingredient Hotlist	Against UK-specific restricted substances

A practical order of operations

1. Pull your existing CNF ingredient list and concentrations as your starting draft, not your final answer.
2. Confirm or establish a UK Responsible Person before anything else, since the filing structurally needs one.
3. Re-check every ingredient against current UK restricted and prohibited substance guidance, not against the Canadian Hotlist.
4. Rebuild the label for UK requirements rather than translating the Canadian one.
5. File through SCPN with the UK-specific data set, treating it as its own filing rather than a copy of the Canadian one.

Where the real risk sits

The place brands get burned isn't usually the filing mechanics, it's assuming a green light in one market implies a green light in another. Cosmetic Comply is built around exactly this kind of ingredient-by-ingredient screening, INCI and CAS mapped, checked against a market's specific prohibited and restricted lists with a compliance reviewer confirming the result, and Canada is where that's live today, with the UK and other markets expanding the picture over time. If you're moving a product from one market's notification into another, treat your existing paperwork as a very useful head start and nothing more.